The global blood clot retrieval devices market size accounted for USD 1.83 billion in 2024, grew to USD 2.10 billion in 2025 and is predicted to surpass around USD 7.10 billion by 2034, representing a healthy CAGR of 14.50% between 2024 and 2034. The North America blood clot retrieval devices market size is calculated at USD 700 million in 2024 and is expected to grow at a fastest CAGR of 14.60% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Blood Clot Retrieval Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Blood Clot Retrieval Devices Market, by Stroke, 2024-2034
8.1.1. Ischemic Stroke (blood clot)
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Hemorrhagic Stroke (rupturing of arteries)
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Transient Ischemic Attack
8.1.3.1. Market Revenue and Forecast (2021-2034)
9.1. Blood Clot Retrieval Devices Market, by Devices, 2024-2034
9.1.1. Mechanical Embolus Removal Devices
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Penumbra Blood Clot Retrieval Devices
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Stent Retrievers
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Aspiration Device
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Ultrasound Assisted Devices
9.1.5.1. Market Revenue and Forecast (2021-2034)
10.1. Blood Clot Retrieval Devices Market, by Application, 2024-2034
10.1.1. Coronary Arteries
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Peripheral Arteries
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Cerebral Arteries
10.1.3.1. Market Revenue and Forecast (2021-2034)
11.1. Blood Clot Retrieval Devices Market, by End User, 2024-2034
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Diagnostic Centers
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Clinics
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. Ambulatory Surgical Centers
11.1.4.1. Market Revenue and Forecast (2021-2034)
12.1. North America
12.1.1. Market Revenue and Forecast, by Stroke (2021-2034)
12.1.2. Market Revenue and Forecast, by Devices (2021-2034)
12.1.3. Market Revenue and Forecast, by Application (2021-2034)
12.1.4. Market Revenue and Forecast, by End User (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Stroke (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Devices (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Application (2021-2034)
12.1.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Stroke (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Devices (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Application (2021-2034)
12.1.6.4. Market Revenue and Forecast, by End User (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Stroke (2021-2034)
12.2.2. Market Revenue and Forecast, by Devices (2021-2034)
12.2.3. Market Revenue and Forecast, by Application (2021-2034)
12.2.4. Market Revenue and Forecast, by End User (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Stroke (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Devices (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Application (2021-2034)
12.2.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Stroke (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Devices (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Application (2021-2034)
12.2.6.4. Market Revenue and Forecast, by End User (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Stroke (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Devices (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Application (2021-2034)
12.2.7.4. Market Revenue and Forecast, by End User (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Stroke (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Devices (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Application (2021-2034)
12.2.8.4. Market Revenue and Forecast, by End User (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Stroke (2021-2034)
12.3.2. Market Revenue and Forecast, by Devices (2021-2034)
12.3.3. Market Revenue and Forecast, by Application (2021-2034)
12.3.4. Market Revenue and Forecast, by End User (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Stroke (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Devices (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Application (2021-2034)
12.3.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Stroke (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Devices (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Application (2021-2034)
12.3.6.4. Market Revenue and Forecast, by End User (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Stroke (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Devices (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Application (2021-2034)
12.3.7.4. Market Revenue and Forecast, by End User (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Stroke (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Devices (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Application (2021-2034)
12.3.8.4. Market Revenue and Forecast, by End User (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Stroke (2021-2034)
12.4.2. Market Revenue and Forecast, by Devices (2021-2034)
12.4.3. Market Revenue and Forecast, by Application (2021-2034)
12.4.4. Market Revenue and Forecast, by End User (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Stroke (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Devices (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Application (2021-2034)
12.4.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Stroke (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Devices (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Application (2021-2034)
12.4.6.4. Market Revenue and Forecast, by End User (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Stroke (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Devices (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Application (2021-2034)
12.4.7.4. Market Revenue and Forecast, by End User (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Stroke (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Devices (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Application (2021-2034)
12.4.8.4. Market Revenue and Forecast, by End User (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Stroke (2021-2034)
12.5.2. Market Revenue and Forecast, by Devices (2021-2034)
12.5.3. Market Revenue and Forecast, by Application (2021-2034)
12.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Stroke (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Devices (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Application (2021-2034)
12.5.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Stroke (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Devices (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Application (2021-2034)
12.5.6.4. Market Revenue and Forecast, by End User (2021-2034)
13.1. AngioDynamics
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Terumo Co.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Johnson and Johnson
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. ECKOS Co.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Bayer HealthCare LLC
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Boston Scientific Co.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Argon Medical Devices
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Medtronic Plc
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Teleflex Incorporated
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Penumbra
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample